C146H215ClFN23O7 — CID 158856404
1-tert-butyl-4-methylpyrazole;2-chloro-4-propan-2-ylpyridine;N-cyclopropyl-5-propan-2-ylpyridine-2-carboxamide;2-fluoro-N-methyl-4-propan-2-ylbenzamide;2-methoxy-4-propan-2-ylpyridine;2-methoxy-N-[(5-propan-2-yl-2-pyridinyl)methyl]acetamide;3-methyl-6-propan-2-ylpyridazine;2-methyl-4-propan-2-ylpyridine;tetrakis(2-methyl-5-propan-2-ylpyridine);2-methyl-N-[(5-propan-2-yl-2-pyridinyl)methyl]propanamide;2-methyl-5-propan-2-ylpyrimidine;4-[2-(4-propan-2-ylpyrazol-1-yl)ethyl]morpholine (PubChem CID 158856404) has the molecular formula C146H215ClFN23O7 and a molecular weight of 2458.93 g/mol. Its IUPAC name is 1-tert-butyl-4-methylpyrazole;2-chloro-4-propan-2-ylpyridine;N-cyclopropyl-5-propan-2-ylpyridine-2-carboxamide;2-fluoro-N-methyl-4-propan-2-ylbenzamide;2-methoxy-4-propan-2-ylpyridine;2-methoxy-N-[(5-propan-2-yl-2-pyridinyl)methyl]acetamide;3-methyl-6-propan-2-ylpyridazine;2-methyl-4-propan-2-ylpyridine;tetrakis(2-methyl-5-propan-2-ylpyridine);2-methyl-N-[(5-propan-2-yl-2-pyridinyl)methyl]propanamide;2-methyl-5-propan-2-ylpyrimidine;4-[2-(4-propan-2-ylpyrazol-1-yl)ethyl]morpholine.
| Compound Name | 1-tert-butyl-4-methylpyrazole;2-chloro-4-propan-2-ylpyridine;N-cyclopropyl-5-propan-2-ylpyridine-2-carboxamide;2-fluoro-N-methyl-4-propan-2-ylbenzamide;2-methoxy-4-propan-2-ylpyridine;2-methoxy-N-[(5-propan-2-yl-2-pyridinyl)methyl]acetamide;3-methyl-6-propan-2-ylpyridazine;2-methyl-4-propan-2-ylpyridine;tetrakis(2-methyl-5-propan-2-ylpyridine);2-methyl-N-[(5-propan-2-yl-2-pyridinyl)methyl]propanamide;2-methyl-5-propan-2-ylpyrimidine;4-[2-(4-propan-2-ylpyrazol-1-yl)ethyl]morpholine |
|---|---|
| PubChem CID | 158856404 |
| Molecular Formula | C146H215ClFN23O7 |
| Molecular Weight | 2458.93 g/mol |
| Exact Mass | 2456.68 |
| IUPAC Name | 1-tert-butyl-4-methylpyrazole;2-chloro-4-propan-2-ylpyridine;N-cyclopropyl-5-propan-2-ylpyridine-2-carboxamide;2-fluoro-N-methyl-4-propan-2-ylbenzamide;2-methoxy-4-propan-2-ylpyridine;2-methoxy-N-[(5-propan-2-yl-2-pyridinyl)methyl]acetamide;3-methyl-6-propan-2-ylpyridazine;2-methyl-4-propan-2-ylpyridine;tetrakis(2-methyl-5-propan-2-ylpyridine);2-methyl-N-[(5-propan-2-yl-2-pyridinyl)methyl]propanamide;2-methyl-5-propan-2-ylpyrimidine;4-[2-(4-propan-2-ylpyrazol-1-yl)ethyl]morpholine |
| SMILES | CC(C)C(=O)NCc1ccc(C(C)C)cn1.CC(C)c1ccc(C(=O)NC2CC2)nc1.CC(C)c1ccnc(Cl)c1.CC(C)c1cnn(CCN2CCOCC2)c1.CNC(=O)c1ccc(C(C)C)cc1F.COCC(=O)NCc1ccc(C(C)C)cn1.COc1cc(C(C)C)ccn1.Cc1cc(C(C)C)ccn1.Cc1ccc(C(C)C)cn1.Cc1ccc(C(C)C)cn1.Cc1ccc(C(C)C)cn1.Cc1ccc(C(C)C)cn1.Cc1ccc(C(C)C)nn1.Cc1cnn(C(C)(C)C)c1.Cc1ncc(C(C)C)cn1 |
| InChI | InChI=1S/C13H20N2O.C12H21N3O.C12H18N2O2.C12H16N2O.C11H14FNO.C9H13NO.5C9H13N.C8H10ClN.C8H14N2.2C8H12N2/c1-9(2)11-5-6-12(14-7-11)8-15-13(16)10(3)4;1-11(2)12-9-13-15(10-12)4-3-14-5-7-16-8-6-14;1-9(2)10-4-5-11(13-6-10)7-14-12(15)8-16-3;1-8(2)9-3-6-11(13-7-9)12(15)14-10-4-5-10;1-7(2)8-4-5-9(10(12)6-8)11(14)13-3;1-7(2)8-4-5-10-9(6-8)11-3;1-7(2)9-4-5-10-8(3)6-9;4*1-7(2)9-5-4-8(3)10-6-9;1-6(2)7-3-4-10-8(9)5-7;1-7-5-9-10(6-7)8(2,3)4;1-6(2)8-4-9-7(3)10-5-8;1-6(2)8-5-4-7(3)9-10-8/h5-7,9-10H,8H2,1-4H3,(H,15,16);9-11H,3-8H2,1-2H3;4-6,9H,7-8H2,1-3H3,(H,14,15);3,6-8,10H,4-5H2,1-2H3,(H,14,15);4-7H,1-3H3,(H,13,14);4-7H,1-3H3;5*4-7H,1-3H3;3-6H,1-2H3;5-6H,1-4H3;2*4-6H,1-3H3 |
| InChIKey | JACKWYDXZVTNSU-UHFFFAOYSA-N |
| XLogP | 33.09 |
| TPSA | 363.43 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 178 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2458.93 |
| LogP ≤ 5 | 33.09 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 26 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|